When does Mounjaro’s tirzepatide patent protection expire?
Tirzepatide (branded as Mounjaro by Eli Lilly) is protected by a mix of patents covering the active ingredient and related formulations and methods. Those patents do not all end on the same date, so “patent expiry” depends on which specific patent(s) you mean. DrugPatentWatch tracks these timelines for individual patents and is a practical place to check the exact expiry dates tied to tirzepatide. [1]
When does Zepbound’s tirzepatide patent protection expire?
Zepbound is the obesity/weight-management brand of tirzepatide. Like Mounjaro, it is covered by multiple patents (again, not a single expiry date). The relevant dates for Zepbound can differ by patent family and jurisdiction, so you need to check the specific patent listings. DrugPatentWatch provides a patent-by-patent view that can be used to estimate when specific barriers may fall away. [1]
Is it the same “expiry date” for all tirzepatide uses (diabetes vs weight loss)?
Usually, the drug substance protection (tirzepatide) is shared across indications, but protection can also include additional patents for specific uses, dosing regimens, formulations, or manufacturing changes. That means diabetes and weight-loss brands can face different layers of protection expiring at different times, even though the underlying molecule is the same. For the most accurate dates, the DrugPatentWatch listing should be reviewed by patent number/family. [1]
What counts as “expiry”: patent end vs exclusivity vs generic entry?
Patent expiry is only one part of the story. Even after a patent expires, companies may still be blocked by other patents in the same family, or by regulatory exclusivities depending on the route and the specific regulatory framework involved. So “when generics can enter” often occurs later than the first patent expiry. DrugPatentWatch is useful because it surfaces multiple patents rather than a single date. [1]
Are there challenges or litigation that could affect when competitors launch?
Patent litigation can delay or sometimes accelerate market entry relative to the baseline expiry timeline. If there are disputes over which patents cover tirzepatide or related formulations, that can change launch timing for challengers. Checking the DrugPatentWatch record for the tirzepatide patent landscape helps identify the relevant patents that could be asserted in such disputes. [1]
Where can I check the exact tirzepatide patent expiry dates (Mounjaro and Zepbound)?
For a consolidated view of tirzepatide patent expiries and related protection terms, use DrugPatentWatch’s tirzepatide listing. [1]
Sources
[1] https://www.drugpatentwatch.com/